What Is Inflammaging? A Simple Guide

Inflammaging is the low, steady hum of inflammation that tends to rise as we age, even in the absence of infection or injury. It is one of the more useful ideas in modern aging biology, and it connects directly to how our cells and immune systems manage energy. Here is a clear, honest explainer.

What inflammaging actually means

The word is a blend of inflammation and aging, coined by researchers to describe a specific pattern: a chronic, low-grade, sterile inflammatory state that develops gradually over the years. Sterile means it is not driven by a pathogen. Low-grade means it usually sits far below the intense, obvious inflammation of an acute illness, often detectable only through sensitive blood markers rather than any dramatic symptom.

Short-term inflammation is protective and essential; it is how the body fights infection and repairs damage. The concern with inflammaging is not inflammation itself but its persistence. When low-level inflammatory signaling stays switched on for years, it is thought to gradually wear on tissues. Researchers describe inflammaging as a shared feature that appears alongside many age-related changes, which is why it has become a focus of longevity science.

Where the signals come from

Inflammaging does not have a single cause. It is better understood as the sum of several drifting processes that each add a little inflammatory noise.

Cellular debris and stress signals

As tissues age, they accumulate molecules that the immune system reads as danger signals, sometimes called damage-associated molecular patterns. These are normal cellular components that end up in the wrong place, and their presence can quietly keep immune sensors activated.

Senescent cells

Some cells stop dividing but do not clear away. These senescent cells can secrete a mix of inflammatory messengers, contributing to the background signal over time.

The immune system's own aging

The immune system remodels with age, a process often called immunosenescence. The balance of immune cell types shifts, and the system can become both less precise against new threats and more prone to baseline activation.

The mitochondrial and immune-cell connection

One of the most interesting threads in this research is the link between inflammaging and mitochondria, the structures that produce cellular energy. Immune cells are metabolically demanding: when they patrol, respond, and resolve, they draw heavily on mitochondrial output. Healthy immune function depends on immune cells having well-functioning mitochondria.

Mitochondria also sit close to the inflammatory machinery for a structural reason. They descend from ancient bacteria, and some of their internal contents, including their own DNA, can be read by the immune system as danger signals if they leak out of damaged mitochondria. In this way, mitochondria that are worn out or poorly cleared can become a source of inflammatory signaling rather than clean energy. That is why cellular housekeeping, the recycling of damaged mitochondria known as mitophagy, keeps appearing in discussions of inflammaging. You can read our primer on what mitophagy is and our broader overview of mitochondrial health for the underlying biology.

Urolithin A and immune-cell mitochondria: what the newest human data shows

This mitochondrial angle is where urolithin A enters the conversation. Urolithin A is a gut postbiotic: certain gut bacteria convert ellagitannins from pomegranate, walnuts, and berries into it, and not everyone's microbiome does so efficiently. Its most studied action is support for mitophagy. Our complete urolithin A guide covers the compound in full.

The most directly relevant human study is a 2025 randomized controlled trial published in Nature Aging. Over roughly 28 days in midlife adults, it reported that urolithin A supported the mitochondrial health of immune cells, a finding the authors situated within the biology of inflammaging. Read carefully, this is a structure-and-function observation about immune-cell mitochondria; it is not a demonstration that urolithin A treats or prevents any inflammatory disease.

It helps to place this against the wider evidence, organized by strength. The strongest and most repeated human findings for urolithin A concern muscle. In JAMA Network Open in 2022, Liu, D'Amico and colleagues studied older adults over about four months and reported improved muscle endurance. In Cell Reports Medicine in 2022, Singh and colleagues tested 500 mg and 1,000 mg daily arms in middle-aged adults over four months for muscle strength and exercise performance. Tolerability was established earlier: Andreux and colleagues, in Nature Metabolism in 2019, found urolithin A safe and well tolerated up to 1,000 mg per day and detected a mitochondrial gene-expression signature. The 2025 immune-mitochondria result is newer and, being a single short trial, should be read as an early human signal rather than a mature body of evidence.

The foundational mechanism itself is preclinical. Ryu and colleagues, in Nature Medicine in 2016, showed in animal and cell models that urolithin A stimulated mitophagy, improved muscle function in rodents, and extended lifespan in the roundworm C. elegans. That is laboratory origin, not human proof. A 2024 systematic review in Ageing Research Reviews reasonably concluded that the human evidence for urolithin A and aging is still emerging, drawn from short trials of modest size.

A note on scope and safety

Inflammation sits close to many medical conditions, from cardiovascular and metabolic disease to autoimmune and joint disorders. It is important to be precise: urolithin A is a dietary supplement studied for how it supports normal cellular and mitochondrial processes. It is not a treatment for inflammation, immune disease, or any age-related condition, and nothing here should be taken as a claim that it prevents disease. If you have symptoms, a diagnosed condition, or specific concerns about inflammation or immune health, this is a topic to raise with your doctor rather than to self-manage with a supplement.

Everyday factors that shape your inflammatory baseline

Much of what influences low-grade inflammation is behavioral, and these levers are well supported and freely available.

Move regularly

Physical activity is one of the most consistent influences on a healthier inflammatory profile, and it strongly supports mitochondrial quality. Our note on exercise and mitochondrial health explains why movement remains the primary lever.

Prioritize sleep

Short or fragmented sleep is associated with higher inflammatory markers. Protecting sleep is one of the simplest ways to support a calmer baseline.

Eat a plant-rich pattern

Diets rich in colorful plants, including the pomegranate, walnuts, and berries that supply ellagitannins, are broadly associated with lower chronic inflammation. Because ellagitannin conversion to urolithin A varies between people, some choose a standardized dose; the clinically studied range is 500 to 1,000 mg per day, with 1,000 mg at the top. See the best urolithin A gummies comparison for how products stack up.

Manage the obvious stressors

Excess body fat, chronic stress, and smoking all push the inflammatory baseline upward. Addressing them yields broad benefits well beyond any single marker.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.